Relebactam Anhydrous

CHEMBL3112741 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
348.4 g/mol
LogP
-3.6
Phase
4

Relebactam anhydrous is the anhydrous form of relebactam, a diazabicyclooctane beta-lactamase inhibitor combined with imipenem-cilastatin for treatment of resistant Gram-negative bacterial infections. See relebactam for complete pharmacological details.

الوزن الجزيئي

348,3800 g/mol

LogP

-3,60

TPSA

137,00 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O

InChI

InChI=1S/C12H20N4O6S/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21)/t9-,10+/m1/s1

Molecular Formula

C12H20N4O6S

HBD / HBA

3 / 7

الروابط القابلة للدوران

4

الذرات الثقيلة

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

Relebactam anhydrous is the anhydrous form of relebactam, a diazabicyclooctane beta-lactamase inhibitor combined with imipenem-cilastatin for treatment of resistant Gram-negative bacterial infections. See relebactam for complete pharmacological details.

Yes, Relebactam Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3112741. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 44129647. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.